GSK and CureVac to develop next generation mRNA COVID-19 vaccines
GlaxoSmithKline plc and CureVac N.V. announced a new €150m collaboration, building on their existing relationship, to jointly develop next generation mRNA vaccines for COVID-19...
Oxford leads first trial investigating dosing with alternating vaccines
The University of Oxford is to lead the first trial to explore alternating different COVID-19 vaccines, to explore the potential for flexibility in delivery...
Moderna Provides Business Update and Announces Three New Development Programs in Infectious Disease Vaccines
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that it is expanding its pipeline of innovative vaccines with three...
Merck, Pfizer get EU nod for Bavencio as bladder cancer maintenance
Pfizer and partner Merck KGaA now have approval on both sides of the Atlantic for their checkpoint inhibitor Bavencio as a first-line maintenance therapy...
Boehringer Ingelheim and Enara Bio Partner on Cancer Immunotherapies
Boehringer Ingelheim and Enara Bio, a science-led company targeting the T-cell/cancer-cell interface for the development of cancer immunotherapies, announced that they have entered into...
Pfizer Invests $120 Million in Biotechnology Innovation
Pfizer announced on Jan. 12, 2021 that, during the second half of 2020, it invested a total of $120 million in four clinical-stage biotech...
Baxter Biopharma Announces Sterile Manufacturing Agreement for Novavax COVID-19 Vaccine
Baxter International announced Baxter BioPharma Solutions has entered into an agreement to provide sterile manufacturing services for NVX-CoV2373, Novavax’ COVID-19 recombinant nanoparticle vaccine candidate...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...